Forced COX-2 expression induces PGE(2) and invasion in immortalized urothelial cells (Q39998452)

16 September 2017

Forced COX-2 expression induces PGE(2) and invasion in immortalized urothelial cells (English)

1 reference

16 September 2017

Jason Gee

1

1 reference

16 September 2017

I-Ling Lee

series ordinal

2

1 reference

16 September 2017

H Barton Grossman

series ordinal

3

1 reference

16 September 2017

Anita L Sabichi

series ordinal

4

1 reference

16 September 2017

8 January 2008

1 reference

16 September 2017

1 reference

16 September 2017

26

1 reference

16 September 2017

6

1 reference

16 September 2017

641-645

1 reference

The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis

16 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.05.015

Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.05.015

Raising the safety bar--the FDA's coxib meeting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.05.015

Chemoprevention of superficial bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.05.015

A phase I study of 5-fluorouracil, leucovorin, and celecoxib in patients with incurable colorectal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.05.015

Docetaxel and cyclooxygenase-2 inhibition with celecoxib for advanced non-small cell lung cancer progressing after platinum-based chemotherapy: a multicenter phase II trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.05.015

Cyclooxygenase-2 inhibitor celecoxib augments chemotherapeutic drug-induced apoptosis by enhancing activation of caspase-3 and -9 in prostate cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.05.015

Structure of the human cyclo-oxygenase-2 gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.05.015

High quality RNA isolation from tumours with low cellularity and high extracellular matrix component for cDNA microarrays: application to chondrosarcoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.05.015

Overexpression of cyclooxygenase-2 is sufficient to induce tumorigenesis in transgenic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.05.015

Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.05.015

Prostaglandin E2 increases growth and motility of colorectal carcinoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.05.015

Increased cyclooxygenase-2 levels in carcinogen-induced rat colonic tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.05.015

Aspirin use and the risk for colorectal cancer and adenoma in male health professionals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.05.015

Non-steroidal anti-inflammatory drugs and bladder cancer prevention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.05.015

Cytokeratin 20, AN43, PGDH, and COX-2 expression in transitional and squamous cell carcinoma of the bladder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.05.015

10.1016/J.UROLONC.2007.05.015

7 January 2021

Identifiers

DOI

1 reference

16 September 2017

1 reference